GTBP

GT Biopharma, Inc. GTBP

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GTBP ARTL PTIX CARM SLRX WINT PBM SLXN LIPO DRMA
6M -74.63 % -71.75 % -65.17 % -90.25 % -96.13 % -92.98 % -80.92 % -79.64 % -87.82 % 227.02 %
YTD -73.68 % -75.08 % -82.94 % -90.23 % -97.45 % -99.76 % -93.76 % -91.66 % -93.68 % 58.99 %
1Y -72.46 % -71.70 % -83.42 % -88.92 % -97.17 % -99.75 % -94.55 % -93.44 % -93.52 % 79.67 %
3Y -97.70 % -90.94 % -95.05 % -99.57 % -99.53 % -100.00 % -99.98 % -99.05 % -99.44 % -94.83 %
5Y -99.70 % -97.10 % -99.02 % -99.83 % -99.97 % -100.00 % -99.98 % -99.05 % -96.50 % -99.82 %
10Y -100.00 % -99.61 % -99.02 % -99.93 % -100.00 % -100.00 % -99.98 % -99.05 % -96.50 % -99.82 %
From the beginning -100.00 % -99.61 % -99.02 % -99.98 % -100.00 % -100.00 % -99.98 % -99.05 % -96.50 % -99.82 %

Dividend

Protagenic Therapeutics, Inc.

Carisma Therapeutics, Inc.